Treatment of Psychotic Depression with Combination Olanzapine/Sertraline

Summary

Results from the National Institute of Mental Health's Study of the Pharmacotherapy of Psychotic Depression [STOP-PD] were presented at the American Psychiatric Association's 2008 Annual Meeting. To investigate the efficacy of a pharmacotherapeutic approach, STOP-PD looked at monotherapy with an antipsychotic versus an antipsychotic/antidepressant combination.

  • personality disorders
  • mood disorders
  • psychopharmacology clinical trials
View Full Text